Zivo Bioscience, Inc.
ZIVO
$17.80
-$0.10-0.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 72.46% | -544.22% | 33.01% | -4.58% | 11.87% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -97.77% | 2.28% |
| Total Other Non-Cash Items | -85.57% | 5,441.33% | 32.33% | 39.22% | 225.55% |
| Change in Net Operating Assets | 140.85% | 106.76% | -151.38% | 347.29% | -147.21% |
| Cash from Operations | -73.96% | 63.29% | -137.40% | 63.66% | -99.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | 245.07% | -- | -100.00% |
| Total Debt Repaid | 0.00% | -200.00% | 95.52% | -536.26% | 0.00% |
| Issuance of Common Stock | 114.32% | -40.18% | 72.39% | -82.39% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 154.77% | -68.82% | 416.16% | -114.40% | 330.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 215.20% | -0.37% | 88.79% | -182.69% | 880.59% |
